85-7206-82 ATM (Ataxia Telangiectasia Mutated, ATA, AT Complementation Group A, ATC, ATD, ATE) 200ul A4000-25

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • Ataxia-telangiectasia (A-T) is a recessive childhood disease caused by mutations in the ATM (AT-mutated) gene.
  • Symptoms include neurological abnormalities that cause unsteady posture, dilated blood vessels, infertility, radiation sensitivity, immune deficiencies and lymphoid malignancies.
  • It appears that the diverse defects seen in ATM null mammals are manifestations of disparate signal transduction defects.
  • The ATM protein is related to a family of proteins through a c-terminal phoshatidylinositol 3-kinase (PI3-kinase) domain.
  • ATM also shares sequence homology with portions of the yeast RAD3 gene.
  • The main role of ATM appears to be induction of a DNA-damage control pathway in response to genotoxic insults, such as ionizing radiation or anti-tumor medications and the programmed DNA breaks of meiosis.
  • Ataxia telangiectasia mutated kinase (ATM) and ataxia telangiectasia and Rad3-related kinase (ATR) are related kinases that regulate cell cycle checkpoints and DNA repair.
  • ATM activates p53, increasing the p21Cip1 levels, thus blocking activation of cdk2.
  • That results in Rb hypophosphorylation and blockage of the G1/S transition.
  • Separately, ATM also phosphorylates and activates Chk1, which phosphorylates cdc25C, preventing it from phosphorylating the inhibitory phosphotyrosine residue on cdc2/cdk1, thus preventiing the G2/M transition.
  • The identified substrates for ATM are p53, p95/NBS1, MDM2, Chk2, BRCA1, CtIP, 4E-BP1 and Chk1.
  • The essential requirement for the substrates of ATM/ATR is S*/T*Q.
  • Hydrophobic amino acids at positions -3 and -1, and negatively charged amino acids at position +1 are positive determinants for substrate recognition by these kinases.
  • Positively charged residues surrounding the S/TQ are negative determinants for substrate phosphorylation.
  • The complex phenotype of AT cells suggests that it must have other cellular substrates as well.
  • Applications:Suitable for use in Western Blot and Immunoprecipitation (reported).
  • Other applications not tested.
  • Recommended Dilution:Western Blot: 1:500 detects ATM in a nuclear extract from Raji cells.
  • Raji nuclear extract was resolved by electrophoresis, transferred to nitrocellulose and probed with anti-ATM.
  • Proteins were visualized using a goat antimouse secondary antibody conjugated to HRP and a chemiluminescence detection system.
  • Optimal dilutions to be determined by the researcher.
  • Storage and Stability:May be stored at 4°C for short-term only.
  • For long-term storage and to avoid repeated freezing and thawing, add sterile glycerol (40-50%), aliquot and store at -20°C or colder.
  • Aliquots are stable for at least 12 months at -20°C.
  • For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
  • Further dilutions can be made in assay buffer.

仕様

  • Size:200ul
  • Host:mouse
  • Source Antibody:human
  • Grade:Ascites
  • Purity:Ascites
  • Form:Supplied as a liquid, 0.05% sodium azide.
  • Specificity:Recognizes human ATM, Mr 350kD.
  • Clone # USB:0.T.04 (AM9)
  • Isotype:IgG
  • Calc Applications Abbrev:IP WB
  • Calc Crossreactivity:Hu
  • Immunogen:Full-length human ATM.
  • Shelf Life:1year
  • Swiss Prot Number:Q13315
  • EU Commodity Code:30021010
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
85-7206-82
型番
A4000-25
入り数
1個
標準価格
247,000円(税抜)
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る